Evidence map›Paper›PMID 37283544›Full record

Observational studyThe Journal of infectious diseases2023

Use of Next-Generation Sequencing in a State-Wide Strategy of HIV-1 Surveillance: Impact of the SARS-COV-2 Pandemic on HIV-1 Diagnosis and Transmission.

Shuntai Zhou, Nathan Long, Matt Moeser, Collin S Hill, Erika Samoff, Victoria Mobley, Simon Frost, Cara Bayer, Elizabeth Kelly, Annalea Greifinger and 7 more

Abstract readObservational Study
In one paragraph

Observational study in The Journal of infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shuntai ZhouLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.ORCID 0000-0002-8353-386X
Nathan LongLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Matt MoeserLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Collin S HillLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Erika SamoffNorth Carolina Department of Health and Human Services, Raleigh, North Carolina, USA.
Victoria MobleyNorth Carolina Department of Health and Human Services, Raleigh, North Carolina, USA.
Simon FrostMicrosoft Health Futures, Microsoft Corporation, Redmond, Washington, USA.ORCID 0000-0002-5207-9879
Cara BayerDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Elizabeth KellyDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Annalea GreifingerDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Scott ShoneNorth Carolina Department of Health and Human Services, Raleigh, North Carolina, USA.
William GloverNorth Carolina Department of Health and Human Services, Raleigh, North Carolina, USA.
Michael ClarkLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Joseph EronDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Myron CohenDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ronald SwanstromLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Ann M DennisDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Funding

HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic PeopleR01AI140970 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ronald I Swanstrom, Shuntai Zhou · 2018 to 2026
$4.1M
Timely monitoring and response to HIV transmission networks for intensified preventionR01AI135970 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DENNIS, ANN · 2018 to 2022
$3.8M
Rapid Response to Incident HIV Infection through Social Network Strategies and Molecular Epidemiology to Inform Partner ServicesR01AI169602 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ann Dennis · 2022 to 2026
$3.6M
NIAID NIH HHS R01 AI135970NIAID NIH HHS R01 AI140970NIAID NIH HHS R01 AI169602NIH HHS R01
6 · The paper itself

Abstract

backgroundThe ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic posed an unpreceded threat to the management of other pandemics such as human immunodeficiency virus-1 (HIV-1) in the United States. The full impact of the SARS-CoV-2 pandemic on the HIV-1 pandemic needs to be evaluated.

methodsAll individuals with newly reported HIV-1 diagnoses from NC State Laboratory of Public Health were enrolled in this prospective observational study, 2018-2021. We used a sequencing-based recency assay to identify recent HIV-1 infections and to determine the days postinfection (DPI) for each person at the time of diagnosis.

resultsSequencing used diagnostic serum samples from 814 individuals with new HIV-1 diagnoses spanning this 4-year period. Characteristics of individuals diagnosed in 2020 differed from those in other years. People of color diagnosed in 2021 were on average 6 months delayed in their diagnosis compared to those diagnosed in 2020. There was a trend that genetic networks were more known for individuals diagnosed in 2021. We observed no major integrase resistance mutations over the course of the study.

conclusionsSARS-CoV-2 pandemic may contribute to the spread of HIV-1. Public health resources need to focus on restoring HIV-1 testing and interrupting active, ongoing, transmission.

Indexed as

COVID-19HIV-1COVID-19 TestingHigh-Throughput Nucleotide SequencingHumansPandemicsSARS-CoV-2United Statesdrug resistance mutationHIV-1recencySARS-CoV-2transmission network

Identifiers

PMID37283544
PMCPMC10733719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.